Alzamend Neuro Inc (NASDAQ:ALZN) does about 1.38M shares in volume on a normal day but saw 2005600 shares change hands in the recent trading day. The company now has a market cap of 3.07M USD. Its current market price is $3.83, marking a decrease of -29.60% compared to the previous close of $5.44. The 52 week high reached by this stock is $135.54 whilst the lowest price level in 52 weeks is $3.06.
The consensus objective for the share price is $180.00, suggesting that the stock has a potential upside of 97.87% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 01, 2021 when Ascendiant Capital Markets initiated the stock to “Buy” and issued a price target of $8.
The current price level is -12.73%, -39.34%, and -67.11% away from its SMA20, SMA50, and SMA200 respectively, with the ALZN price moving above the 50-day SMA on current market day. Alzamend Neuro Inc (ALZN) stock is up 7.58% over the week and -35.52% over the past month. Its price is -63.31% year-to-date and -92.57% over the past year.
To reach the target analysts have set, the stock logically needs to grow 97.87 percent from here.
Outstanding shares total 0.80M with insiders holding 3.22% of the shares and institutional holders owning 0.88% of the company’s common stock. The company has a return on investment of -122.53% and return on equity of -1092.96%. The beta has a value of -0.14. Price to book ratio is 0.72.
